Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor (original) (raw)

• Garver, R.I. Jr. et al. Recurrence of bronchioloalveolar carcinoma in transplanted lungs. N. Engl. J. Med. 340, 1071–1074 (1999).
  Article PubMed Google Scholar
• Meyer, C.G., Penn, I. & James, L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 69, 1633–1637 (2000).
  Article CAS PubMed Google Scholar
• Penn, I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin. Transpl. 147–158 (1998).
• Dumont, F.J., Staruch, M.J., Koprak, S.L., Melino, M.R. & Sigal, N.H. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. J. Immunol. 144, 251–258 (1990).
  CAS PubMed Google Scholar
• Sehgal, S.N. Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin. Biochem. 31, 335–340 (1998).
  Article CAS PubMed Google Scholar
• Wiederrecht, G.J. et al. Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells. Prog. Cell Cycle Res. 1, 53–71 (1995).
  Article CAS PubMed Google Scholar
• Kahan, B.D. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group. Lancet 356, 194–202 (2000).
  Article CAS PubMed Google Scholar
• Shapiro, A.M. et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343, 230–238 (2000).
  Article CAS PubMed Google Scholar
• Schreiber, S.L. & Crabtree, G.R. The mechanism of action of cyclosporin A and FK506. Immunol. Today 13, 136–142 (1992).
  Article CAS PubMed Google Scholar
• Ondrus, D. et al. The incidence of tumours in renal transplant recipients with long-term immunosuppressive therapy. Int. Urol. Nephrol. 31, 417–422 (1999).
  Article CAS PubMed Google Scholar
• Zhong, H. et al. Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 60, 1541–1545 (2000).
  CAS PubMed Google Scholar
• Semenza, G.L. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol. 15, 551–578 (1999).
  Article CAS PubMed Google Scholar
• Sanchez-Elsner, T. et al. Synergistic cooperation between hypoxia and transforming growth factor-β pathways on human vascular endothelial growth factor gene expression. J. Biol. Chem. 38527–38535 (2001).
• Schwarte-Waldhoff, I. et al. Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. Proc. Natl. Acad. Sci. USA 97, 9624–9629 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Zheng, W., Seftor, E.A., Meininger, C.J., Hendrix, M.J. & Tomanek, R.J. Mechanisms of coronary angiogenesis in response to stretch: role of VEGF and TGF-β. Am. J. Physiol. Heart Circ. Physiol. 280, H909–H917 (2001).
  Article CAS PubMed Google Scholar
• Carmeliet, P. & Jain, R.K. Angiogenesis in cancer and other diseases. Nature 407, 249–257 (2000).
  Article CAS PubMed Google Scholar
• Guba, M. et al. A primary tumor promotes dormancy of solitary tumor cells before inhibiting angiogenesis. Cancer Res. 61, 5575–5579 (2001).
  CAS PubMed Google Scholar
• Eng, C.P., Sehgal, S.N. & Vezina, C. Activity of rapamycin (AY-22,989) against transplanted tumors. J. Antibiot. (Tokyo) 37, 1231–1237 (1984).
  Article CAS Google Scholar
• Asaishi, K., Endrich, B., Gotz, A. & Messmer, K. Quantitative analysis of microvascular structure and function in the amelanotic melanoma A-Mel-3. Cancer Res. 41, 1898–1904 (1981).
  CAS PubMed Google Scholar
• Fukumura, D., Yuan, F., Monsky, W.L., Chen, Y. & Jain, R.K. Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. Am. J. Pathol. 151, 679–688 (1997).
  CAS PubMed PubMed Central Google Scholar
• Fukumura, D. et al. Tumor induction of VEGF promoter activity in stromal cells. Cell 94, 715–725 (1998).
  Article CAS PubMed Google Scholar
• Ferrara, N. The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res. Treat. 36, 127–137 (1995).
  Article CAS PubMed Google Scholar
• Vinals, F., Chambard, J.C. & Pouyssegur, J. p70 S6 kinase–mediated protein synthesis is a critical step for vascular endothelial cell proliferation. J. Biol. Chem. 274, 26776–26782 (1999).
  Article CAS PubMed Google Scholar
• Yu, Y. & Sato, J.D. MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor. J. Cell Physiol. 178, 235–246 (1999).
  Article CAS PubMed Google Scholar
• Ilan, N., Mahooti, S. & Madri, J.A. Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis. J. Cell Sci. 111, 3621–3631 (1998).
  Article CAS PubMed Google Scholar
• Dayanir, V., Meyer, R.D., Lashkari, K. & Rahimi, N. Identification of tyrosine residues in vascular endothelial growth factor receptor-2/FLK-1 involved in activation of phosphatidylinositol 3-kinase and cell proliferation. J. Biol. Chem. 276, 17686–17692 (2001).
  Article CAS PubMed Google Scholar
• Browder, T. et al. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug–resistant cancer. Cancer Res. 60, 1878–1886 (2000).
  CAS PubMed Google Scholar
• Folkman, J., Browder, T. & Palmblad, J. Angiogenesis research: guidelines for translation to clinical application. Thromb. Haemost. 86, 23–33 (2001).
  Article CAS PubMed Google Scholar
• Klement, G. et al. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. J. Clin. Invest 105, R15–R24 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Gohongi, T. et al. Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: involvement of transforming growth factor β1. Nature Med. 5, 1203–1208 (1999).
  Article CAS PubMed Google Scholar
• Iurlaro, M. et al. Antiangiogenesis by cyclosporine. Exp. Hematol. 26, 1215–1222 (1998).
  CAS PubMed Google Scholar
• Benelli, U., Ross, J.R., Nardi, M. & Klintworth, G.K. Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A. Invest. Ophthalmol. Vis. Sci. 38, 274–282 (1997).
  CAS PubMed Google Scholar
• Hojo, M. et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 397, 530–534 (1999).
  Article CAS PubMed Google Scholar
• Brattain, M.G., Strobel-Stevens, J., Fine, D., Webb, M. & Sarrif, A.M. Establishment of mouse colonic carcinoma cell lines with different metastatic properties. Cancer Res. 40, 2142–2146 (1980).
  CAS PubMed Google Scholar
• Saunders, R.N., Metcalfe, M.S. & Nicholson, M.L. Rapamycin in transplantation: a review of the evidence. Kidney Int. 59, 3–16 (2001).
  Article CAS PubMed Google Scholar
• Drixler, T.A. et al. Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy. Cancer Res. 60, 1761–1765 (2000).
  CAS PubMed Google Scholar
• Guba, M. et al. Differential effects of short-term ACE- and AT1-receptor inhibition on postischemic injury and leukocyte adherence in vivo and in vitro. Shock 13, 190–196 (2000).
  Article CAS PubMed Google Scholar
• Bruns, C.J. et al. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases. Cancer 89, 488–499 (2000).
  Article CAS PubMed Google Scholar
• Salomon-Nhuyen, F. et al. The t(1;12)(q21;p13) translocation of human acute myeloblastic leukemia results in a TEL–ARNT fusion. Proc. Natl. Acad. Sci. USA 97, 6557–6762 (2000).
  Google Scholar
• Hajitou, A. et al. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis. Cancer Res. 61, 3450–3457 (2001).
  CAS PubMed Google Scholar
• Overbergh, L., Valckx, D., Waer, M. & Mathieu, C. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11, 305–312 (1999).
  Article CAS PubMed Google Scholar